Vijay Ramaswamy

Assistant Professor

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Medical Imaging Medical Imaging professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Vijay Ramaswamy is an Assistant Professor at the University of Toronto, Canada. His research focuses on pediatric brain tumors, particularly medulloblastoma and ependymoma, as evidenced by his recent publications exploring screening practices, treatment consensus, and the gut–brain axis. He aims to improve outcomes and management strategies for children affected by these conditions.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (14)

Sumit Gupta

University of Toronto

CANADA

View details

Derek S. Tsang

CANADA

View details

Mark Gilbert

Branch Chief

National Institutes of Health

UNITED STATES

View details

Katja von Hoff

Aarhus University

DENMARK

View details

Chantel Cacciotti

Western University

CANADA

View details

Denise Obrecht-Sturm

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Stephanie Vairy

Institut Gustave Roussy

FRANCE

View details

Bruce Crooks

Associate Professor

Dalhousie University

CANADA

View details

Tamra Werbowetski-Ogilvie

University of Manitoba

UNITED STATES

View details

Juliette Hukin

Clinical Associate Professor

The University of British Columbia

CANADA

View details

Nada Jabado

Professor

McGill University

CANADA

View details

Eric Bouffet

University of Toronto

CANADA

View details

Paul C. Nathan

CANADA

View details

pejman Jabehdar Maralani

Associate Professor

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vijay Ramaswamy

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

How long should survivors of pediatric medulloblastoma and ependymoma be screened for recurrence? A retrospective cohort study

A national modified Delphi consensus on the referral and management of NF1 plexiform neurofibroma

Mind over microbes: targeting the gut–brain axis to improve treatment of pediatric low-grade glioma

Medulloblastoma Molecular Subgrouping and Outcomes Data of a Single Center From a Low‐ and Middle‐Income Country

Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres

Incidence and management of posterior fossa syndrome in children at a tertiary care hospital in Karachi: A 10-year retrospective cohort

Canadian Consensus for Treatment of BRAF <i>V600E</i> Mutated Pediatric and AYA Gliomas

Distinct relapse pattern across molecular ependymoma types

Brain Tumor Imaging in Adolescents and Young Adults: 2021 WHO Updates for Molecular-based Tumor Types

The medical and functional burden of surviving childhood ependymoma: A population‐based study in Ontario, Canada

Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation–Sparing Approaches: An International Cohort Study

Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression

The Burden of Surviving Childhood Medulloblastoma: A Population-Based, Matched Cohort Study in Ontario, Canada

Postmortem Tissue Donation: Giving Families the Ability to Choose

WNT Medulloblastoma Limbo: How Low Can We Go?

How do we approach the management of medulloblastoma in young children?

A novel central nervous system embryonal tumor successfully treated with multi‐modal therapy highlights limitation of methylation‐based tumor classification

Abnormalities of structural brain connectivity in pediatric brain tumor survivors

Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country

Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel?

Collaborators (14)

Sumit Gupta

Derek S. Tsang

Mark Gilbert

Katja von Hoff

Chantel Cacciotti

Denise Obrecht-Sturm

Stephanie Vairy

Bruce Crooks

Tamra Werbowetski-Ogilvie

Juliette Hukin

Nada Jabado

Eric Bouffet

Paul C. Nathan

pejman Jabehdar Maralani

Make your next move.